Recent Breakthrough of Bismuth-Based Nanostructured Materials for Multimodal Theranostic Applications

Cancer is a lethal disease ravaging mankind claiming millions of lives. Most frequent methods of management include surgery, radiotherapy, chemotherapy, or a combination of all the above-mentioned methods. However, there is no specific medication available to cure this condition completely and sever...

Full description

Saved in:
Bibliographic Details
Published in:Journal of nanomaterials 2022, Vol.2022 (1)
Main Authors: Ganapathy, Dhanraj, Shivalingam, Chitra, Shanmugam, Rajeshkumar, Sundramoorthy, Ashok K., Murthykumar, Karthikeyan, Pitchiah, Sivaperumal, Sekaran, Saravanan, Ramachandran, Sathish Kumar
Format: Article
Language:English
Subjects:
Bismuth oxides
Bismuth trioxide
Breast cancer
Cancer
Cancer therapies
Chemotherapy
Contrast agents
Drug dosages
Enzymes
Fatalities
Gold
Hyperthermia
Immunotherapy
Iodine
Lung cancer
Medical research
Nanomaterials
Nanoparticles
Nanostructured materials
Photodynamic therapy
Prostate
Quantum dots
Radiation therapy
Radioisotopes
X-rays
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cancer is a lethal disease ravaging mankind claiming millions of lives. Most frequent methods of management include surgery, radiotherapy, chemotherapy, or a combination of all the above-mentioned methods. However, there is no specific medication available to cure this condition completely and several compounds and drugs are constantly explored for their therapeutic effects. Recently, photothermal therapy, photodynamic therapy, radiotherapy, targeted drug delivery, and hyperthermia have shown to be of great interest in cancer treatment. In this direction, bismuth oxide (Bi2O3) nanoparticles can be a promising option in cancer treatment and diagnosis as well. Bi is a well-known radioactive isotope; this emits high-energy gamma (γ) rays to the affected cells. This technology can pair with existing chemotherapy to enhance the therapeutic efficacy.
ISSN:1687-4110
1687-4129
DOI:10.1155/2022/4944320